Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Gynecologic Oncology Année : 2022

Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)

Résumé

Since 2010, the network of rare malignant tumors of the ovary (TMRG) was developed to optimize the management of patients, also allowing a histological second opinion of rare ovarian tumors. The aim of this work was to study the contribution of second opinion to improve histological diagnostic accuracy on ovarian rare malignant tumors included in the TMRG database.

Dates et versions

hal-03857604 , version 1 (17-11-2022)

Identifiants

Citer

S. Henno, C. Jeanne, T de la Motte Rouge, C. Genestie, I. Treilleux, et al.. Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG). Gynecologic Oncology, 2022, 165 (3), pp.637-641. ⟨10.1016/j.ygyno.2022.03.019⟩. ⟨hal-03857604⟩
66 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More